PDF herunterladen
Thromb Haemost 1978; 39(03): 616-563
DOI: 10.1055/s-0038-1646735
Original Article
Schattauer GmbH Stuttgart

Inhibition of Urokinase by Complex Formation with Human Antithrombin III in Absence and Presence of Heparin

Inge Clemmensen
The Department of Clinical Chemistry, Hvidovre Hospital, DK-2650 Hvidovre, Denmark
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 28. Juli 1977

Accepted 24. November 1977

Publikationsdatum:
12. Juli 2018 (online)

Auch verfügbar auf
  als PDF herunterladen  Lizenzen und Reprints

Summary

Human antithrombin III was purified from fresh human plasma by affinity chromatography on heparin-Sepharose®, affinity chromatography on concanavalin A Sepharose®, gel filtration on Ultrogel® AcA 34, ion exchange chromatography on DEAE A-50 Sephadex® and preparative agarose gel electrophoresis. The hydrolytic activity of urokinase (plasminogen activator from urine) on acetyl-glycyl-L-lysine methyl ester acetate (Ac-gly-lys-OMe Ac) was inhibited by antithrombin III in a slow time-dependent manner. Heparin accelerated the reaction between activator and inhibitor. Inhibition of catalytic activity was associated with the formation of an 1:1 molar complex between activator and inhibitor as revealed by sodium dodecyl sulphate polyacrylamide gel electrophoresis. The complex was also demonstrated by crossed Immunoelectrophoresis against anti-antithrombin III.

 

  • References

  • 1 Abildgaard U, Fagerhol MK, Egeberg O. 1970; Comparison of progressive antithrombin activity and the concentrations of three thrombin inhibitors in human plasma. Scandinavian Journal of Clinical and Laboratory Investigation 26: 349
    CrossrefPubMedGoogle Scholar
  • 2 Aoki N, Von Kaulla KN. 1971; Human serum plasminogen antiactivator: its distinction from antiplasmin. American Journal of Physiology 220: 1137
    PubMedGoogle Scholar
  • 3 Aoki N, Von Kaulla KN. 1971; The extraction of vascular plasminogen ativator from human cadavers and a description of some of its properties. American Journal of Clinical Pathology 55: 171
    CrossrefPubMedGoogle Scholar
  • 4 Astrup T. 1966; Tissue activators of plasminogen. Federation Proceedings 25: 42
    PubMedGoogle Scholar
  • 5 Bachmann F, Fletcher AP, Alkjaersig N, Sherry S. 1964; Partial purification and properties of the plasminogen activator from pig heart. Biochemistry 3: 1578
    CrossrefPubMedGoogle Scholar
  • 6 Bernik MB, Kwan HC. 1967; Origin of fibrinolytic activity in cultures of the human kidney. Journal of Laboratory and Clinical Medicine 70: 650
    PubMedGoogle Scholar
  • 7 Biggs R, Denson KWE, Akman N, Borrett R, Hadden M. 1970; Antithrombin 3, antifactor Xa and heparin. British Journal of Haematology 19: 283
    CrossrefPubMedGoogle Scholar
  • 8 Burrowes CE, Habal FM, Movat HZ. 1975; The inhibition of human plasma kallikrein by antithrombin III. Thrombosis Research 7: 175
    CrossrefPubMedGoogle Scholar
  • 9 Clemmensen I, Christensen F. 1976; Inhibition of urokinase by complex formation with human α1-antitrypsin. Biochimica et biophysica acta 429: 591
    CrossrefPubMedGoogle Scholar
  • 10 Clemmensen L, Thorsen S, Müllertz S. 1976; Purification of a plasminogen activator inhibitor indistinguishable from α1-antitrypsin and an urokinase inhibitor in pregnancy plasma. Haemostasis 5: 218
    PubMedGoogle Scholar
  • 11 Collen D, Cock FD, Verstraete M. 1975; Immunochemical distinction between antiplasmin and alpha1-antitrypsin. Thrombosis Research 7: 245
    CrossrefPubMedGoogle Scholar
  • 12 Collen D. 1976; Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. European Biochimistry 69: 209
    PubMedGoogle Scholar
  • 13 Crawford GPM, Ogston D. 1975; The action of antithrombin III on plasmin and activators of plasminogen. Biochimica et biophysica acta 391: 189
    CrossrefPubMedGoogle Scholar
  • 14 Gallimore MJ. 1975; Serum inhibitors of fibrinolysis. British Journal of Haematology 31: 217
    CrossrefPubMedGoogle Scholar
  • 15 Ganrot PO. 1972; Crossed Immunoelectrophoresis. Scandinavian Journal of Clinical and Laboratory Investigations 29 Suppl (Suppl. 124) 39
    CrossrefPubMedGoogle Scholar
  • 16 Hedner U. 1973; Studies on an inhibitor of plasminogen activation in human serum. Thrombosis et Diathesis Haemorrhagica 30: 414
    PubMedGoogle Scholar
  • 17 Heimburger N. 1975. Proteinase inhibitors of human plasma-their properties and control function. In: Reich E, Rifkin DB, Shaw E. (Eds.) Proteases and Biological Control. Cold Spring Harbor Laboratory; USA: 367
    Google Scholar
  • 18 Highsmith RF, Rosenberg RD. 1974; The inhibition of human plasmin by human antithrombin-heparin cofactor. Journal of Biological Chemistry 249: 4335
    PubMedGoogle Scholar
  • 19 Kawano T, Morimoto K, Uemura Y. 1970; Partial purification and properties of urokinase inhibitor from human placenta. The Journal of Biochemistry 67: 333
    CrossrefPubMedGoogle Scholar
  • 20 Lahiri B, Bagdasarien A, Mitchell B, Talamo RC, Colman RW, Rosenberg RD. 1976; Antithrombin-Heparin Cofactor: An Inhibitor of Plasma Kallikrein. Archives of Biochemistry and Biophysics 175: 737
    CrossrefPubMedGoogle Scholar
  • 21 Landmann H, Markwardt F. 1970; Irreversible synthetische Inhibitoren der Urokinase. Experientia 26: 145
    CrossrefPubMedGoogle Scholar
  • 22 Laurell CB. 1972; Electroimmuno assay. Scandinavian Journal of Clinical and Laboratory Investigations 29 Suppl (Suppl. 124) 39
    CrossrefPubMedGoogle Scholar
  • 23 Moroi M, Aoki N. 1976; Isolation and characterization of α2-plasmin inhibitor from human plasma. Journal of Biological Chemistry 251: 5956
    PubMedGoogle Scholar
  • 24 Müllertz S. 1972; Molecular forms of plasmin and protease inhibitors in human fibrinolytic postmortem plasma. Scandinavian Journal of Clinical and Laboratory Investigations 20: 113
    PubMedGoogle Scholar
  • 25 Müllertz S. 1974; Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin. Biochemical Journal 143: 273
    CrossrefPubMedGoogle Scholar
  • 26 MüLLERTZ S, Clemmensen I. 1976; The primary inhibitor of plasmin in human plasma. Biochemical Journal 159: 545
    CrossrefPubMedGoogle Scholar
  • 27 Ong EB, Johnson AL, Schoellmann P. 1976; Identification of an active site histidine in urokinase. Biochimica et biophysica acta 429: 252
    CrossrefPubMedGoogle Scholar
  • 28 Rimon A, Shamash Y, Shapiro B. 1966; The Plasmin inhibitor of human plasma. Journal of Biological Chemistry 241: 5102
    PubMedGoogle Scholar
  • 29 Robbins KC, Bernabe P, Arzadan L, Summaria L. 1973; The histidine loop of human plasmin: light (B) chain active center histidine sequence. Journal of Biological Chemistry 248: 1631
    PubMedGoogle Scholar
  • 30 Rosenberg RD. 1974; The effect of heparin on factor XIa and plasmin. Thrombosis et Diathesis Haemorrhagica 33: 51
    PubMedGoogle Scholar
  • 31 Rosenberg RD, Damus PS. 1973; The purification and mechanism of action of human antithrombin-heparin cofactor. Journal of Biological Chemistry 248: 6490
    PubMedGoogle Scholar
  • 32 Sawjer WD, Fletcher AP, Alkjaersig N. 1960; Studies on the thrombolytic activity of human plasma. Journal of Clinical Investigation 39: 426
    CrossrefPubMedGoogle Scholar
  • 33 Seegers WH, Cole ER, Harmison CR, Monkhouse FC. 1964; Neutralization of autoprothrombin C activity by antithrombin. Canadian Journal of Biochemistry 42: 359
    CrossrefPubMedGoogle Scholar
  • 34 Stead N, Kaplan AP, Rosenberg RD. 1976; Inhibition of activated factor XII by antithrombin-heparin cofactor. Journal of Biological Chemistry 251: 6481
    PubMedGoogle Scholar
  • 35 Takeda Y, Parkhill TR, Nakabayashi M. 1972; Effects of heparin and E-ammocaproide acid in dogs on plasmin-125I generation in response to urokinase injections and venous injury. Journal of Clinical Investigation 51: 2678
    CrossrefPubMedGoogle Scholar
  • 36 Telesforo P, Semeraro M, Verstrate M, Collen C. 1975; Inhibition of plasmin by antithrombin III-heparin complex in vitro in human plasma and during streptokinase therapy in man. Thrombosis Research 7: 669
    CrossrefPubMedGoogle Scholar
  • 37 Uszynsky M, Abildgaard U. 1971; Separation and characterization of two fibrinolytic inhibitors from human placenta. Thrombosis et Diathesis Haemorrhagica 25: 580
    PubMedGoogle Scholar
  • 38 Vennerød AM, Laake K. 1975; Inhibition of purified plasma kallikrein by antithrombin III and heparin. Thrombosis Research 7: 223
    CrossrefPubMedGoogle Scholar
  • 39 White WF, Barlow GH, Mozen MM. 1966; The isolation and characterization of plasminogen activators (urokinase) from human urine. Biochemistry 5: 2160
    CrossrefPubMedGoogle Scholar
  • 40 Yin ET, Wessler S, Stoll P. 1971; Identity of plasma-activated factor X inhibitor with antithrombin III and heparin cofactor. Journal of Biological Chemistry 246: 3712
    PubMedGoogle Scholar